Morbius Movie Delayed To Late January 2022

It's only a week, but is still further out than previously expected.


Sony Pictures has announced that the upcoming Spider-Man spinoff Morbius has once again been delayed. Thankfully, this time it's only been pushed a week from January 21, 2022 to January 28, 2022. News of the release calendar update issued by Sony also clarifies that Morbius will screen in both IMAX and premium large formats.

The movie is based on the Marvel comic book Morbius: The Living Vampire, and stars Jared Leto as a biologist with a rare blood disease, who gains the powers of a vampire when he performs an experiment involving vampire bat DNA. The official synopsis continues: "Dangerously ill with a rare blood disorder, and determined to save others suffering his same fate, Dr. Morbius attempts a desperate gamble. What at first appears to be a radical success, a darkness inside him is unleashed and transforms this healer into a hunter."

Morbius also stars Matt Smith (Doctor Who), Adria Arjona (Good Omens), Jared Harris (The Terror), and Tyrese Gibson (the Fast & Furious series). The film is directed by Daniel Espinosa (Life, Safe House).

Morbius is one of several movies based on Spider-Man characters that Sony is planning. The Venom sequel, Venom: Let There Be Carnage, is currently scheduled for a June release, although, of course, that could be delayed as well--Morbius was previously delayed a few times. Last year, it was reported that Jessica Jones director S.J. Clarkson had been hired to work on a female-focused project--possibly Madame Webb--while Supergirl and Arrow writer Marc Guggenheim is writing a Jackpot movie. In addition, films focusing on Black Cat, Silver Sable, Silk, and Kraven the Hunter have all been rumored over the past couple of years.

David Wolinsky on Google+

The products discussed here were independently chosen by our editors. GameSpot may get a share of the revenue if you buy anything featured on our site.

Got a news tip or want to contact us directly? Email

Join the conversation
There are 2 comments about this story